Neko's proprietary scanning technology differs from standard methods like MRI, incorporating routine blood tests and advanced imaging techniques.

The company claims to provide more insights than traditional check-ups, which typically occur only after symptoms arise.

Neko Health aims to transform the healthcare landscape by shifting from a reactive to a proactive approach through technological advancements and consumer demand.

This new funding will accelerate Neko's global expansion, particularly into the U.S. market, and enhance its research and development efforts in health diagnostics.

Since its launch in February 2023, Neko has conducted 10,000 health scans in London and Stockholm, with a remarkable 80% of users scheduling follow-up scans.

The company advocates for regular health maintenance, suggesting annual scans for optimal health monitoring, similar to mandatory vehicle inspections.

Neko Health, a Swedish healthtech startup co-founded by Daniel Ek and Hjalmar Nilsonne, has successfully raised $260 million in a Series B funding round, boosting its valuation to $1.7 billion.

Currently, Neko's body scan services are available in London and Stockholm, with plans for further expansion across Europe and into the U.S.

The company has seen a surge in demand, with its global waitlist exceeding 100,000 individuals, indicating strong interest in its services.

For £299, customers undergo comprehensive health examinations that assess various health parameters, including skin cancer risk and cardiovascular health.

The Neko Body Scan evaluates multiple health indicators, such as blood pressure, blood sugar levels, and skin conditions, detecting changes as small as 0.2 millimeters.

Dr. Vishal Gulati emphasized the importance of empowering individuals to engage in their health proactively, aligning with Neko's mission of preventative care.